Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J Edgar

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|January 15, 2008
Cognition assessment in paediatric clinical trialsChris J Edgar, Keith A Wesnes
Current Opinion in Pharmacology|February 26, 2014
The role of human cognitive neuroscience in drug discovery for the dementiasKeith A Wesnes, Chris J Edgar
Journal of Psychopharmacology (Oxford, England)|March 25, 2016
The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trialSujana Reddy, Rana Fayyad, Chris J Edgar, et al.
Psychopharmacology|April 18, 2013
Effects of nicotine withdrawal on cognition in a clinical trial settingKeith A Wesnes, Chris J Edgar, Iva Kezic, et al.
Drug Discovery Today|January 24, 2021
Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug developmentAlette M Wessels, Chris J Edgar, Pradeep J Nathan, et al.
Frontiers in Digital Health|December 9, 2021
A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced DifficultyJoshua P White, Adrian Schembri, Chris J Edgar, et al.
Psychiatry Research|May 10, 2014
Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptomsChris J Edgar, Thomas Blaettler, Dragana Bugarski-Kirola, et al.
Journal of Alzheimer'S Disease : JAD|August 9, 2021
Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2Chris J Edgar, Eric Siemers, Paul Maruff, et al.
Neuroscience Applied|April 10, 2026
Application of the research domain criteria in early-phase clinical development of transdiagnostic neurotherapeutics: A multidisciplinary perspectiveIgor Magaraggia, Franco Di Cesare, Jordi Alonso, et al.
CNS Spectrums|October 2, 2014
Psychometric evaluation of the Work Readiness Questionnaire in schizophreniaSteven G Potkin, Dragana Bugarski-Kirola, Chris J Edgar, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|January 15, 2008
Cognition assessment in paediatric clinical trialsChris J Edgar, Keith A Wesnes
Current Opinion in Pharmacology|February 26, 2014
The role of human cognitive neuroscience in drug discovery for the dementiasKeith A Wesnes, Chris J Edgar
Journal of Psychopharmacology (Oxford, England)|March 25, 2016
The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trialSujana Reddy, Rana Fayyad, Chris J Edgar, et al.
Psychopharmacology|April 18, 2013
Effects of nicotine withdrawal on cognition in a clinical trial settingKeith A Wesnes, Chris J Edgar, Iva Kezic, et al.
Drug Discovery Today|January 24, 2021
Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug developmentAlette M Wessels, Chris J Edgar, Pradeep J Nathan, et al.
Frontiers in Digital Health|December 9, 2021
A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced DifficultyJoshua P White, Adrian Schembri, Chris J Edgar, et al.
Psychiatry Research|May 10, 2014
Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptomsChris J Edgar, Thomas Blaettler, Dragana Bugarski-Kirola, et al.
Journal of Alzheimer'S Disease : JAD|August 9, 2021
Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2Chris J Edgar, Eric Siemers, Paul Maruff, et al.
Neuroscience Applied|April 10, 2026
Application of the research domain criteria in early-phase clinical development of transdiagnostic neurotherapeutics: A multidisciplinary perspectiveIgor Magaraggia, Franco Di Cesare, Jordi Alonso, et al.
CNS Spectrums|October 2, 2014
Psychometric evaluation of the Work Readiness Questionnaire in schizophreniaSteven G Potkin, Dragana Bugarski-Kirola, Chris J Edgar, et al.
Pageof 2